4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-21-000016
Chairman, CEO & President sold 12,468 shares at an average $378.17 ($4,714,965)
From the SEC's structured data for this filing
Trades in this filing
SAYER KEVIN R · Chairman, CEO & President
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-01 | Sale : show line 1 in the form | −800 | $373.44 | $298,751 | 143,602 | D |
| 2021-02-01 | Sale : show line 2 in the form | −400 | $374.47 | $149,787 | 143,202 | D |
| 2021-02-01 | Sale : show line 3 in the form | −2,323 | $376.05 | $873,555 | 140,879 | D |
| 2021-02-01 | Sale : show line 4 in the form | −1,406 | $376.91 | $529,932 | 139,473 | D |
| 2021-02-01 | Sale : show line 5 in the form | −1,350 | $378.11 | $510,446 | 138,123 | D |
| 2021-02-01 | Sale : show line 6 in the form | −1,095 | $379.20 | $415,223 | 137,028 | D |
| 2021-02-01 | Sale : show line 7 in the form | −5,094 | $380.30 | $1,937,272 | 131,934 | D |
| Open-market sales · 12,468 sh · avg $378.17 · $4,714,965 | ||||||
Loading xslF345X03/edgardoc.xml…